| 09:00 - 10:30 |
Concurrent scientific working group session III |
09:00 - 10:30
H1 |
Stem cell in disease modeling & drug development
supported by bit.bio
(Chairs: Oliver Brüstle & Karl-Ludwig Laugwitz) |
| 09:00 - 09:30 |
T26 - iPSCs in drug discovery – from a user’s and a personal perspective
Bert Klebl, Lead Discovery Center (LDC), Dortmund |
| 09:30 - 09:45 |
T27 - Patient-specific iPSC-derived hepatic organoids as model for drug dosing and mRNA-based gene therapy
Malte Sgodda, Hannover Medical School (MHH) |
| 09:45 - 10:00 |
T28 - Human multi-tissue organoids as an advanced teratogenicity model
Liam Wilson, Hannover Medical School (MHH) |
| 10:00 - 10:15 |
T29 - Cellular metabolism senses exogenous fatty acids to reprogram dormant tumour cells into aggressive oncogenic cell states
Patricia Inacio, Max Planck Institute of Molecular Cell Biology and Genetics, Dresden |
| 10:15 - 10:30 |
T30 - iPSC modeling of bipolar disorder 1 based on polygenic risk scores
Tamara Krutenko, University of Bonn |
09:00 - 10:30
H2 |
Hematopoietic stem cells
(Chairs: Marieke Essers & Mick Milsom) |
| 09:00 - 09:30 |
T31 - The bonemarrow niche under stress
Marieke Essers, DKFZ & HI-Stem, Heidelberg |
| 09:30 - 09:45 |
T32 - Apelin signaling restricts the formation of the blood stem cell-forming hemogenic endothelium
Jean Eberlein, University of Marburg |
| 09:45 - 10:00 |
T33/P - Intrinsic reconstitution potential of developmentally restricted hematopoietic stem cells in non-conditioned immunocompromised mice
Marcel G.E. Rommel, UC Santa Cruz |
| 10:00 - 10:15 |
T34 - Metabolic atlas of human bone marrow hematopoietic stem cells upon differentiation, aging and leukemia
Maria Eleni Lalioti, MPI-IE, Freiburg |
| 10:15 - 10:30 |
T35 - The function of PD-L2 expression on human hematopoietic stem cells in allogeneic immune regulation at single cell resolution
Tessa Schmachtel, University Hospital Frankfurt |
09:00 - 10:30
H3 |
Stem cells in regenerative therapies supported by Eppendorf SE
(Chairs: Michael Cross & Ulrich Martin) |
| 09:00 - 09:30 |
T36 - Tracking of early cell fate decisions of iPSCs based on DNA methylation
Wolfgang Wagner, RWTH Aachen |
| 09:30 - 09:45 |
T37 - Pooled mesenchymal stromal cells fail to represent average donor cell characteristics
Janina Burk, vetmeduni, Vienna, AT |
| 09:45 - 10:00 |
T38/P - Humanized osteoclasts: an interspecies chimeric immune cell
Gülce Percin, Leibniz Institute on Aging/FLI, Jena |
| 10:00 - 10:15 |
T39 - Resolving human alpha versus beta cell fate allocation for the generation of stem cell-derived islets
Corinna Cozzitorto, Helmholtz Center Munich |
| 10:15 - 10:30 |
T40 - Generation of designer stem cell-derived islets (SC-islets) to improve safety and efficacy of SC-based islet replacement therapy
Eunike Setyono, Helmholtz Center Munich |
| 10:30 - 11:00 |
Break time / Industry exhibition |
| 11:00 - 12:30 |
Concurrent strategic working group session |
11:00 - 12:30
H1 |
Clinical trials & regulatory affairs
(Chairs: Zoltán Ivics & Andreas Kurtz) |
| 11:00 - 11:30 |
S1 - Exploring public and government funding opportunities
Bettina Otto, Berlin Institute of Health (BIH) |
| 11:30 - 12:00 |
S2 - High-Tech Gründerfonds - early stage seed investments
Christian Kannemeier, High-Tech Gründerfonds, Berlin |
| 12:00 - 12:30 |
S3 - The National Office for Gene- and Cell Therapies (GCT): updates on activities and future impact
Elke Luger, GCT National Network Orrice, Berlin |
11:00 - 12:30
H2 |
Career development
(Chairs: Marieke Essers & Insa Schroeder) |
| |
S4 - Publish or perish - feed back from a journal editor
Achim Breiling, EMBO Reports, Heidelberg |
11:00 - 12:30
H3 |
Technologies in stem cell research
(Chairs: Sebastian Diecke & Sebastian Knöbel) |
| 11:00 - 11:30 |
S5 - Cellular microenvironments fabricated with fluid walls for disease modeling
Edmond Walsh, University of Oxford, UK |
| 11:30 - 12:00 |
S6 - Combining stem cell and device engineering for in vitro models of human physiology
Anna Herland, KTH Royal Institute of Technology, Solna, SE |
| 12:00 - 12:30 |
S7 - Stem cell-derived vessels-on-chip for cardiovascular disease modeling
Matthias Meier, Helmholtz Center Munich |
| 12:30 - 14:00 |
Lunch break / Industry exhibition supported by Sartorius |
14:00 - 14:45
H1 |
Keynote lecture IV
K4 - Colorful aging? an aging-specific platelet differentiation path from hematopoietic stem cells
Camilla Forsberg, UC Santa Cruz, US
Chair: Meritxell Huch |
14:45 - 15:30
H1 |
Keynote lecture V
K5 - Bat induced pluripotent stem cells as a model for viral tolerance and immunity
Thomas Zwaka, Icahn School of Medicine at Mount Sinai, New York, US
Chair: Heiko Lickert |
|
15:30 - 15:50
H1
|
Poster award ceremony
Daniel Besser
Poster awards supported by Thermo Fisher Scientific
Travel awards |
15:50 - 16:00
H1 |
Closing remarks by the GSCN president
Heiko Lickert |
| |
End of GSCN Conference 2024 |